About: Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol for the treatment of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Latest price: $1.11 (-5.56%)
CRDL NASDAQ Cardiol Therapeutics Inc Class A
Cardiol Therapeutics Inc Class A share price
CRDL price activity
Last Price
$1.110
Change (24hr)
-0.07 USD (5.56%)
Volume
261.46K
Volume (4w avg)
-
Open
$1.16
Day Range
$1.10 - $1.16
Previous Close
$1.17
Last Trade
30 Oct, 4:15 pm GMT+0
Delayed
30 Oct, 4:15 pm GMT+0
CRDL price performance
Delayed
30 Oct, 4:15 pm GMT+0
CRDL Market Signals